查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1473853

全球系統性麴菌症/系統性念珠菌症市場（2024 年版）：按類型、治療方法、最終用戶、地區和國家、市場洞察和預測進行分析（2020-2030 年）

Global Systemic Aspergillosis and Systemic Candidiasis Market (2024 Edition): Analysis By Type (Candidiasis, Aspergillosis), By Treatment Approach, By End User, By Region, By Country: Market Insights and Forecast (2020-2030)
出版日期: | 出版商: Azoth Analytics | 英文 250 Pages | 訂單完成後即時交付

價格

2020-2023年，全球系統性麴菌症/系統性念珠菌症市場規模複合年成長率為3.62%。

2023年市場規模為71.8億美元，預計2030年將達96.2億美元。可支配收入水準的上升，尤其是富人的可支配收入水準的上升，正在推動對優質抗老化手術和護膚產品的需求。

麴菌症和念珠菌症是世界上最常見的真菌感染疾病，常見於免疫力較弱的人，例如移植受者、接受化療的癌症患者以及愛滋病毒/愛滋病感染者。這些感染疾病可表現為嚴重的感染疾病、感染疾病或侵襲性性行為感染，如果不及時診斷和治療，會導致嚴重的發病率和死亡率。

系統性麴菌症/系統性念珠菌症的治療以抗真菌藥物為主，其中Azole、棘白菌素類和Polyenes是主要的治療選擇。如果標準治療無效或出現抗藥性，這些藥物也可以一起使用。在某些情況下，例如侵襲性肺部麴菌症或真菌性心內膜炎，可能需要手術作為輔助性治療。

由於真菌感染疾病的增加、診斷方法的改進、醫療保健專業人員和人們意識的提高以及抗真菌治療的擴大，市場正在獲得動力。此外，人口老化、免疫抑制治療和醫院感染等因素也在推動市場擴張。

該市場的特點是來自製藥公司和醫療機構等主要企業的激烈競爭。這些公司不斷創新並推出新產品和解決方案，以滿足醫療保健提供者、實驗室和患者不斷變化的需求。

該報告研究了全球系統性麴菌症/系統性念珠菌症市場，並提供包括市場規模和預測、區域和細分分析以及主要趨勢和機會在內的資訊。

目錄

第1章 市集背景

  • 產品範圍和產品前景
  • 執行摘要
  • 調查方法

第2章 分析師建議

  • 個人化醫療
  • 拓展新興市場

第3章全球系統性麴菌症/系統性念珠菌症市場：表現與預測

  • 宏觀經濟因素對全球系統性麴菌症/系統性念珠菌症市場的影響分析
  • 常見致命真菌感染疾病的年發生率
  • 系統性麴菌症/系統性念珠菌症的抗真菌治療正在開發中
  • 全球系統性麴菌症/系統性念珠菌症市場：儀表板
  • 全球系統性麴菌症/系統性念珠菌症市場：市場規模和複合年成長率（2020-2030）
  • 全球系統性麴菌症/系統性念珠菌症市場：市場金額評估
  • 評估 COVID-19 對全球系統性麴菌症/系統性念珠菌症市場的影響
  • 全球系統性麴菌症/系統性念珠菌症市場細分：按類型
    • 全球系統性麴菌症/系統性念珠菌症市場：按類型、概述
    • 全球系統性麴菌症/系統性念珠菌症市場吸引力指數：按類型
    • 全球系統性麴菌症/系統性念珠菌症市場規模：念珠菌症（金額）（2020-2030）
    • 全球系統性麴菌症/系統性念珠菌症市場規模：麴菌症（金額）（2020-2030）
  • 全球系統性麴菌症/系統性念珠菌症市場細分：依治療方法
    • 全球系統性麴菌症/系統性念珠菌症市場：依治療方法分類，概述
    • 全球系統性麴菌症/系統性念珠菌症市場吸引力指數：依治療方法
    • 全球系統性麴菌症/系統性念珠菌症市場規模：抗真菌藥物（金額）（2020-2030）
    • 全球系統性麴菌症/系統性念珠菌症市場規模：聯合治療（金額）（2020-2030）
    • 全球系統性麴菌症/系統性念珠菌症市場規模：手術（金額）（2020-2030）
  • 全球系統性麴菌症/系統性念珠菌症市場細分：按最終用戶分類
    • 全球系統性麴菌症/系統性念珠菌症市場概述：按最終用戶分類
    • 全球系統性麴菌症/系統性念珠菌症市場吸引力指數：依最終用戶分類
    • 全球系統性麴菌症/系統性念珠菌症市場規模：醫院（金額）（2020-2030）
    • 全球系統性麴菌症/系統性念珠菌症市場規模：診所（金額）（2020-2030）
    • 全球系統性麴菌症/系統性念珠菌症市場規模：其他最終用戶（金額）（2020-2030）

第4章全球系統性麴菌症/系統性念珠菌症市場，區域分析

  • 研究的區域範圍
  • 區域簡介

第5章美洲系統性麴菌症/系統性念珠菌症市場：表現與預測

  • 美洲系統性麴菌症/系統性念珠菌症市場：簡介
  • 美洲系統性麴菌症/系統性念珠菌症市場：市場規模和複合年成長率（2020-2030）
  • 美洲系統性麴菌症/系統性念珠菌症市場：主要促進因素
  • 美洲系統性麴菌症/系統性念珠菌症市場：細分分析
  • 美洲系統性麴菌症/系統性念珠菌症市場細分：按類型
  • 美洲系統性麴菌症/系統性念珠菌症市場細分：依治療方法
  • 按最終用戶分類的美洲系統性麴菌症/系統性念珠菌症市場細分
  • 按國家/地區分類的美洲系統性麴菌症/系統性念珠菌症市場細分
    • 美洲系統性麴菌症/系統性念珠菌症市場：按國家/地區分類，概述
    • 美國系統性麴菌症/系統性念珠菌症市場：市場規模和複合年成長率（2020-2030）
    • 加拿大系統性麴菌症/系統性念珠菌症市場：市場規模和複合年成長率（2020-2030）
    • 其他美洲系統性麴菌症/系統性念珠菌症市場：市場規模和複合年成長率（2020-2030）

第6章歐洲系統性麴菌症/系統性念珠菌症市場：表現與預測

  • 歐洲系統性麴菌症/系統性念珠菌症市場：簡介
  • 歐洲系統性麴菌症/系統性念珠菌症市場：市場規模和複合年成長率（2020-2030）
  • 歐洲系統性麴菌症/系統性念珠菌症市場：主要促進因素
  • 歐洲系統性麴菌症/系統性念珠菌症市場：細分分析
  • 歐洲系統性麴菌症/系統性念珠菌症市場細分：按類型
  • 歐洲系統性麴菌症/系統性念珠菌症市場細分：依治療方法
  • 歐洲系統性麴菌症/系統性念珠菌症市場細分：按最終用戶
  • 歐洲系統性麴菌症/系統性念珠菌症市場細分：按國家/地區
    • 歐洲系統性麴菌症/系統性念珠菌症市場：按國家/地區分類，概述
    • 德國系統性麴菌症/系統性念珠菌症市場：市場規模和複合年成長率（2020-2030）
    • 英國系統性麴菌症/系統性念珠菌症市場：市場規模和複合年成長率（2020-2030）
    • 法國系統性麴菌症/系統性念珠菌症市場：市場規模和複合年成長率（2020-2030）
    • 義大利系統性麴菌症/系統性念珠菌症市場：市場規模和複合年成長率（2020-2030）
    • 西班牙系統性麴菌症/系統性念珠菌症市場：市場規模和複合年成長率（2020-2030）
    • 其他歐洲系統性麴菌症/系統性念珠菌症市場：市場規模和複合年成長率（2020-2030）

第7章亞太地區系統性麴菌症/系統性念珠菌症市場：實際與預測

  • 亞太地區系統性麴菌症/系統性念珠菌症市場：概況
  • 亞太地區系統性麴菌症/系統性念珠菌症市場：市場規模和複合年成長率（2020-2030）
  • 亞太地區系統性麴菌症/系統性念珠菌症市場：主要促進因素
  • 亞太地區系統性麴菌症/系統性念珠菌症市場：細分分析
  • 亞太地區系統性麴菌症/系統性念珠菌症市場細分：按類型
  • 亞太地區系統性麴菌症/系統性念珠菌症市場區隔：依治療方法
  • 亞太地區系統性麴菌症/系統性念珠菌症市場細分：依最終用戶分類
  • 亞太地區系統性麴菌症/系統性念珠菌症市場細分：按國家/地區
    • 亞太地區系統性麴菌症/系統性念珠菌症市場：按國家/地區分類，概述
    • 中國系統性麴菌症/系統性念珠菌症市場：市場規模及複合年成長率（2020-2030）
    • 日本系統性麴菌症/系統性念珠菌症市場：市場規模和複合年成長率（2020-2030）
    • 印度系統性麴菌症/系統性念珠菌症市場：市場規模和複合年成長率（2020-2030）
    • 其他亞太地區系統性麴菌症/系統性念珠菌症市場：市場規模和複合年成長率（2020-2030）

第 8 章中東和非洲系統性麴菌症/系統性念珠菌症市場：表現和預測

  • 中東和非洲系統性麴菌症/系統性念珠菌症市場：簡介
  • 中東和非洲系統性麴菌症/系統性念珠菌症市場：市場規模和複合年成長率（2020-2030）
  • 中東和非洲系統性麴菌症/系統性念珠菌症市場：主要促進因素
  • 中東和非洲系統性麴菌症/系統性念珠菌症市場：細分分析
  • 中東和非洲系統性麴菌症/系統性念珠菌症市場細分：按類型
  • 中東和非洲系統性麴菌症/系統性念珠菌症市場細分：按治療方法
  • 中東和非洲系統性麴菌症/系統性念珠菌症最終用戶市場細分

第9章市場動態

  • 評估市場動態對系統性麴菌症/系統性念珠菌症市場的影響
  • 促進因素
  • 抑制因素
  • 趨勢

第10章產業生態系分析

  • 波特分析

第11章競爭定位

  • 企業產品定位
  • 市場地位矩陣
  • 系統性麴菌症/系統性念珠菌症市場市場佔有率分析
  • 公司簡介
    • Sanofi
    • Cipla
    • Pfizer
    • GSK PLC
    • Novartis AG
    • Bayer AG
    • Merck & Co., Inc.
    • F. Hoffmann-La Roche AG
    • Abbott Laboratories
    • Gilead Sciences, Inc.

第12章 關於我們公司、免責聲明

Executive Summary

Azoth Analytics has released a research report titled "Global Systemic Aspergillosis and Systemic Candidiasis Market (2024 Edition)" which provides a complete analysis of the Global Systemic Aspergillosis and Systemic Candidiasis industry in terms of market segmentation By Type (Candidiasis, Aspergillosis), By Treatment Approach (Antifungal Medications, Combination Therapy, and Surgical Intervention) By End Users (Hospitals, Clinics, Other End-users) for the historical period of 2020-2023, the estimates of 2024 and the forecast period of 2025-2030.

The report analyses the Global Systemic Aspergillosis and Systemic Candidiasis Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India). The Global Systemic Aspergillosis and Systemic Candidiasis market showcased growth at a CAGR of 3.62% during 2020-2023.

The market was valued at USD 7.18 Billion in 2023 which is expected to reach USD 9.62 Billion in 2030. Growing disposable income levels, particularly among affluent consumers, have fuelled demand for premium anti-aging Surgical Intervention and skincare products.

Aspergillosis and candidiasis are among the most common fungal infections worldwide, affecting individuals with compromised immune systems, such as transplant recipients, cancer patients

undergoing chemotherapy, and those with HIV/AIDS. These infections can manifest as severe pulmonary, bloodstream, or invasive infections, leading to substantial morbidity and mortality if not promptly diagnosed and treated.

Antifungal drugs continue to serve as the foundation for treating systemic aspergillosis and systemic candidiasis, with azoles, echinocandins, and polyenes representing the primary

treatment options. Combinations of these medications may be utilized in cases where standard therapy proves ineffective or to combat instances of emerging drug resistance. In certain

scenarios, such as invasive pulmonary aspergillosis or fungal endocarditis, surgical procedures may be warranted as adjunctive therapy.

The Global Systemic Aspergillosis and Systemic Candidiasis Market experiences momentum due to rising occurrences of fungal infections, improved diagnostic methods, heightened awareness among healthcare practitioners and individuals, and the expanding array of antifungal treatments. Furthermore, factors such as population aging, immunosuppressive treatments, and hospital- acquired transmissions bolster the market's expansion.

The market is characterized by intense competition among key players, including pharmaceutical companies, and healthcare organizations. These companies are continuously innovating and launching new products and solutions to meet the evolving needs of healthcare providers, laboratories, and patients.

Scope of the Report:

  • The report analyses the Systemic Aspergillosis and Systemic Candidiasis Market by Value (USD Billion).
  • The report analyses the Systemic Aspergillosis and Systemic Candidiasis Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada,

Germany, United Kingdom, France, Italy, Spain, China, Japan, India).

  • The report presents the analysis of Systemic Aspergillosis and Systemic Candidiasis Market for the historical period of 2020-2023, the estimated year 2024 and the forecast period of 2025-2030.
  • The report analyses the Systemic Aspergillosis and Systemic Candidiasis Market By Type (Candidiasis, Aspergillosis)
  • The report analyses the Systemic Aspergillosis and Systemic Candidiasis Market By Treatment Approach (Antifungal Medications, Combination Therapy, and Surgical Intervention).
  • The report analyses the Systemic Aspergillosis and Systemic Candidiasis Market By End Users (Hospitals, Clinics, and Other End Users).
  • The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis. Also, the attractiveness of the market has been presented by region, By Type, By Treatment Approach and By End User.
  • Also, the major opportunities, trends, drivers, and challenges of the industry has been analyzed in the report.
  • The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Sanofi, Cipla, Pfizer, GSK PLC, Novartis AG, Bayer AG, Merck & Co., Inc., F. Hoffmann-La Roche AG, Abbott Laboratories and Gilead Sciences, Inc.

Table of Contents

Table of Content

1. Market Background

  • 1.1 Scope and Product Outlook
  • 1.2 Executive Summary
  • 1.3 Research Methodology

2. Analyst Recommendations

  • 2.1 Personalized Medicine
  • 2.2 Penetrating Developing Markets

3. Global Systemic Aspergillosis and Systemic Candidiasis Market: Historic and Forecast

  • 3.1 Impact Analysis of Macro Economic Factors on Global Systemic Aspergillosis and Systemic Candidiasis Market
  • 3.2 Annual incidence of commoner life-threatening fungal infections
  • 3.3 Antifungal Therapies for Systemic Aspergillosis And Systemic Candidiasis in Pipeline
  • 3.4 Global Systemic Aspergillosis and Systemic Candidiasis Market: Dashboard
  • 3.5 Global Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
  • 3.6 Global Systemic Aspergillosis and Systemic Candidiasis Market: Market Value Assessment
  • 3.7 Assessment Degree of Impact of COVID-19 on Global Systemic Aspergillosis and Systemic Candidiasis Market
  • 3.8 Global Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Type
    • 3.8.1 Global Systemic Aspergillosis and Systemic Candidiasis Market, By Type Overview
    • 3.8.2 Global Systemic Aspergillosis and Systemic Candidiasis Market Attractiveness Index, By Type
    • 3.8.3 Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Candidiasis, By Value, 2020H-2030F (USD Billion & CAGR)
    • 3.8.4 Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Aspergillosis, By Value, 2020H-2030F (USD Billion & CAGR)
  • 3.9 Global Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Treatment Approach
    • 3.9.1 Global Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach Overview
    • 3.9.2 Global Systemic Aspergillosis and Systemic Candidiasis Market Attractiveness Index, By Treatment Approach
    • 3.9.3 Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Antifungal Medications, By Value, 2020H-2030F (USD Billion & CAGR)
    • 3.9.4 Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Combination Therapy, By Value, 2020H-2030F (USD Billion & CAGR)
    • 3.9.5 Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Surgical Intervention, By Value, 2020H-2030F (USD Billion & CAGR)
  • 3.10 Global Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By End-users
    • 3.10.1 Global Systemic Aspergillosis and Systemic Candidiasis Market, By End-users Overview
    • 3.10.2 Global Systemic Aspergillosis and Systemic Candidiasis Market Attractiveness Index, By End-users
    • 3.10.3 Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Hospitals, By Value, 2020H-2030F (USD Billion & CAGR)
    • 3.10.4 Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Clinics, By Value, 2020H-2030F (USD Billion & CAGR)
    • 3.10.5 Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Other End-users, By Value, 2020H-2030F (USD Billion & CAGR)

4. Global Systemic Aspergillosis and Systemic Candidiasis Market, Region Analysis

  • 4.1 Regional Coverage of the Study
  • 4.2 Regional Snapshot

5. Americas Systemic Aspergillosis and Systemic Candidiasis Market: Historic and Forecast

  • 5.1 Americas Systemic Aspergillosis and Systemic Candidiasis Market: Snapshot
  • 5.2 Americas Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
  • 5.3 Americas Systemic Aspergillosis and Systemic Candidiasis Market: Key Factors
  • 5.4 Americas Systemic Aspergillosis and Systemic Candidiasis Market: Segment Analysis
  • 5.5 Americas Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Type
    • 5.5.1 Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Type Overview
    • 5.5.2 Americas Systemic Aspergillosis and Systemic Candidiasis Market Size, By Candidiasis, By Value, 2020H-2030F (USD Billion & CAGR)
    • 5.5.3 Americas Systemic Aspergillosis and Systemic Candidiasis Market Size, By Aspergillosis, By Value, 2020H-2030F (USD Billion & CAGR)
  • 5.6 Americas Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: Treatment Approach
    • 5.6.1 Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach Overview
    • 5.6.2 Americas Systemic Aspergillosis and Systemic Candidiasis Market Size, By Antifungal Medications, By Value, 2020H-2030F (USD Billion & CAGR)
    • 5.6.3 Americas Systemic Aspergillosis and Systemic Candidiasis Market Size, By Combination Therapy, By Value, 2020H-2030F (USD Billion & CAGR)
    • 5.6.4 Americas Systemic Aspergillosis and Systemic Candidiasis Market Size, By Surgical Intervention, By Value, 2020H-2030F (USD Billion & CAGR)
  • 5.7 Americas Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By End-users
    • 5.7.1 Americas Systemic Aspergillosis and Systemic Candidiasis Market, By End-users Overview
    • 5.7.2 Americas Systemic Aspergillosis and Systemic Candidiasis Market Size, By Hospitals, By Value, 2020H-2030F (USD Billion & CAGR)
    • 5.7.3 Americas Systemic Aspergillosis and Systemic Candidiasis Market Size, By Clinics, By Value, 2020H-2030F (USD Billion & CAGR)
    • 5.7.4 Americas Systemic Aspergillosis and Systemic Candidiasis Market Size, By Other End-users, By Value, 2020H-2030F (USD Billion & CAGR)
  • 5.8 Americas Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Country
    • 5.8.1 Americas Systemic Aspergillosis and Systemic Candidiasis Market, by Country Overview
    • 5.8.2 United States Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 5.8.2.1 United States Systemic Aspergillosis and Systemic Candidiasis Market, By Type
      • 5.8.2.2 United States Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
      • 5.8.2.3 United States Systemic Aspergillosis and Systemic Candidiasis Market, By End-users
    • 5.8.3 Canada Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 5.8.3.1 Canada Systemic Aspergillosis and Systemic Candidiasis Market, By Type
      • 5.8.3.2 Canada Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
      • 5.8.3.3 Canada Systemic Aspergillosis and Systemic Candidiasis Market, By End-users
    • 5.8.4 Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 5.8.4.1 Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Type
      • 5.8.4.2 Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
      • 5.8.4.3 Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market, By End-users

6. Europe Systemic Aspergillosis and Systemic Candidiasis Market: Historic and Forecast

  • 6.1 Europe Systemic Aspergillosis and Systemic Candidiasis Market: Snapshot
  • 6.2 Europe Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
  • 6.3 Europe Systemic Aspergillosis and Systemic Candidiasis Market: Key Factors
  • 6.4 Europe Systemic Aspergillosis and Systemic Candidiasis Market: Segment Analysis
  • 6.5 Europe Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Type
    • 6.5.1 Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Type Overview
    • 6.5.2 Europe Systemic Aspergillosis and Systemic Candidiasis Market Size, By Candidiasis, By Value, 2020H-2030F (USD Billion & CAGR)
    • 6.5.3 Europe Systemic Aspergillosis and Systemic Candidiasis Market Size, By Aspergillosis, By Value, 2020H-2030F (USD Billion & CAGR)
  • 6.6 Europe Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Treatment Approach
    • 6.6.1 Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach Overview
    • 6.6.2 Europe Systemic Aspergillosis and Systemic Candidiasis Market Size, By Antifungal Medications, By Value, 2020H-2030F (USD Billion & CAGR)
    • 6.6.3 Europe Systemic Aspergillosis and Systemic Candidiasis Market Size, By Combination Therapy, By Value, 2020H-2030F (USD Billion & CAGR)
    • 6.6.3 Europe Systemic Aspergillosis and Systemic Candidiasis Market Size, By Surgical Intervention, By Value, 2020H-2030F (USD Billion & CAGR)
  • 6.7 Europe Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By End-users
    • 6.7.1 Europe Systemic Aspergillosis and Systemic Candidiasis Market, By End-users Overview
    • 6.7.2 Europe Systemic Aspergillosis and Systemic Candidiasis Market Size, By Hospitals, By Value, 2020H-2030F (USD Billion & CAGR)
    • 6.7.3 Europe Systemic Aspergillosis and Systemic Candidiasis Market Size, By Clinics, By Value, 2020H-2030F (USD Billion & CAGR)
    • 6.7.4 Europe Systemic Aspergillosis and Systemic Candidiasis Market Size, By Other End-users, By Value, 2020H-2030F (USD Billion & CAGR)
  • 6.8 Europe Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Country
    • 6.8.1 Europe Systemic Aspergillosis and Systemic Candidiasis Market, by Country Overview
    • 6.8.2 Germany Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 6.8.2.1 Germany Systemic Aspergillosis and Systemic Candidiasis Market, By Type
      • 6.8.2.2 Germany Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
      • 6.8.2.3 Germany Systemic Aspergillosis and Systemic Candidiasis Market, By End-users
    • 6.8.3 United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 6.8.3.1 United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market, By Type
      • 6.8.3.2 United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
      • 6.8.3.3 United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market, By End-users
    • 6.8.4 France Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 6.8.4.1 France Systemic Aspergillosis and Systemic Candidiasis Market, By Type
      • 6.8.4.2 France Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
      • 6.8.4.3 France Systemic Aspergillosis and Systemic Candidiasis Market, By End-users
    • 6.8.5 Italy Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 6.8.5.1 Italy Systemic Aspergillosis and Systemic Candidiasis Market, By Type
      • 6.8.5.2 Italy Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
      • 6.8.5.3 Italy Systemic Aspergillosis and Systemic Candidiasis Market, By End-users
    • 6.8.6 Spain Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 6.8.6.1 Spain Systemic Aspergillosis and Systemic Candidiasis Market, By Type
      • 6.8.6.2 Spain Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
      • 6.8.6.3 Spain Systemic Aspergillosis and Systemic Candidiasis Market, By End-users
    • 6.8.7 Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 6.8.7.1 Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Type
      • 6.8.7.2 Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
      • 6.8.7.3 Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market, By End-users

7. Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market: Historic and Forecast

  • 7.1 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market: Snapshot
  • 7.2 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
  • 7.3 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market: Key Factors
  • 7.4 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market: Segment Analysis
  • 7.5 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Type
    • 7.5.1 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Type Overview
    • 7.5.2 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Size, By Candidiasis, By Value, 2020H-2030F (USD Billion & CAGR)
    • 7.5.3 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Size, By Aspergillosis, By Value, 2020H-2030F (USD Billion & CAGR)
  • 7.6 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Treatment Approach
    • 7.6.1 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach Overview
    • 7.6.2 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Size, By Antifungal Medications, By Value, 2020H-2030F (USD Billion & CAGR)
    • 7.6.3 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Size, By Combination Therapy, By Value, 2020H-2030F (USD Billion & CAGR)
    • 7.6.3 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Size, By Surgical Intervention, By Value, 2020H-2030F (USD Billion & CAGR)
  • 7.7 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By End-users
    • 7.7.1 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By End-users Overview
    • 7.7.2 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Size, By Hospitals, By Value, 2020H-2030F (USD Billion & CAGR)
    • 7.7.3 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Size, By Clinics, By Value, 2020H-2030F (USD Billion & CAGR)
    • 7.7.4 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Size, By Other End-users, By Value, 2020H-2030F (USD Billion & CAGR)
  • 7.8 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Country
    • 7.8.1 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, by Country Overview
    • 7.8.2 China Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 7.8.2.1 China Systemic Aspergillosis and Systemic Candidiasis Market, By Type
      • 7.8.2.2 China Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
      • 7.8.2.3 China Systemic Aspergillosis and Systemic Candidiasis Market, By End-users
    • 7.8.3 Japan Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 7.8.3.1 Japan Systemic Aspergillosis and Systemic Candidiasis Market, By Type
      • 7.8.3.2 Japan Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
      • 7.8.3.3 Japan Systemic Aspergillosis and Systemic Candidiasis Market, By End-users
    • 7.8.4 India Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 7.8.4.1 India Systemic Aspergillosis and Systemic Candidiasis Market, By Type
      • 7.8.4.2 India Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
      • 7.8.4.3 India Systemic Aspergillosis and Systemic Candidiasis Market, By End-users
    • 7.8.5 Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 7.8.5.1 Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Type
      • 7.8.5.2 Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
      • 7.8.5.3 Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By End-users

8. Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market: Historic and Forecast

  • 8.1 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market: Snapshot
  • 8.2 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
  • 8.3 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market: Key Factors
  • 8.4 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market: Segment Analysis
  • 8.5 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Type
    • 8.5.1 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market, By Type Overview
    • 8.5.2 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Size, By Candidiasis, By Value, 2020H-2030F (USD Billion & CAGR)
    • 8.5.3 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Size, By Aspergillosis, By Value, 2020H-2030F (USD Billion & CAGR)
  • 8.6 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Treatment Approach
    • 8.6.1 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach Overview
    • 8.6.2 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Size, By Antifungal Medications, By Value, 2020H-2030F (USD Billion & CAGR)
    • 8.6.3 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Size, By Combination Therapy, By Value, 2020H-2030F (USD Billion & CAGR)
    • 8.6.3 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Size, By Surgical Intervention, By Value, 2020H-2030F (USD Billion & CAGR)
  • 8.7 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By End-users
    • 8.7.1 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market, By End-users Overview
    • 8.7.2 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Size, By Hospitals, By Value, 2020H-2030F (USD Billion & CAGR)
    • 8.7.3 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Size, By Clinics, By Value, 2020H-2030F (USD Billion & CAGR)
    • 8.7.4 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Size, By Other End-users, By Value, 2020H-2030F (USD Billion & CAGR)

9. Market Dynamics

  • 9.1 Impact assessment of Market Dynamics on Systemic Aspergillosis and Systemic Candidiasis Market
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Trends

10. Industry Ecosystem Analysis

  • 10.1 Porter Analysis

11. Competitive Positioning

  • 11.1 Companies' Product Positioning
  • 11.2 Market Position Matrix
  • 11.3 Market Share Analysis of Systemic Aspergillosis and Systemic Candidiasis Market
  • 11.4 Company Profiles
    • 11.4.1 Sanofi
    • 11.4.2 Cipla
    • 11.4.3 Pfizer
    • 11.4.4 GSK PLC
    • 11.4.5 Novartis AG
    • 11.4.6 Bayer AG
    • 11.4.7 Merck & Co., Inc.
    • 11.4.8 F. Hoffmann-La Roche AG
    • 11.4.9 Abbott Laboratories
    • 11.4.10 Gilead Sciences, Inc.

12. About Us & Disclaimer

List of Figures

List of Figures

  • Figure 1: Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Value, 2020-2023 (USD Billion)
  • Figure 2: Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Value, 2024-2030 (USD Billion)
  • Figure 3: Global Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, 2023 (%)
  • Figure 4: Market Attractiveness Analysis of Global Systemic Aspergillosis and Systemic Candidiasis Market, By Type (2025-2030)
  • Figure 5: Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Candidiasis, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 6: Global Systemic Aspergillosis and Systemic Candidiasis Market Absolute Opportunity, By Candidiasis, 2020-2030 (USD Billion)
  • Figure 7: Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Aspergillosis, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 8: Global Systemic Aspergillosis and Systemic Candidiasis Market Absolute Opportunity, By Aspergillosis, 2020-2030 (USD Billion)
  • Figure 9: Market Attractiveness Analysis of Global Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach (2025-2030)
  • Figure 10: Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Antifungal Medications, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 11: Global Systemic Aspergillosis and Systemic Candidiasis Market Absolute Opportunity, By Antifungal Medications, 2020-2030 (USD Billion)
  • Figure 12: Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Combination Therapy, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 13: Global Systemic Aspergillosis and Systemic Candidiasis Market Absolute Opportunity, By Combination Therapy, 2020-2030 (USD Billion)
  • Figure 14: Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Surgical Intervention, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 15: Global Systemic Aspergillosis and Systemic Candidiasis Market Absolute Opportunity, By Surgical Intervention, 2020-2030 (USD Billion)
  • Figure 16: Market Attractiveness Analysis of Global Systemic Aspergillosis and Systemic Candidiasis Market, By End-users (2025-2030)
  • Figure 17: Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Hospitals, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 18: Global Systemic Aspergillosis and Systemic Candidiasis Market Absolute Opportunity, By Hospitals, 2020-2030 (USD Billion)
  • Figure 19: Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Clinics, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 20: Global Systemic Aspergillosis and Systemic Candidiasis Market Absolute Opportunity, By Clinics, 2020-2030 (USD Billion)
  • Figure 21: Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Other End-users, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 22: Global Systemic Aspergillosis and Systemic Candidiasis Market Absolute Opportunity, By Other End-users, 2020-2030 (USD Billion)
  • Figure 23: Americas Systemic Aspergillosis and Systemic Candidiasis Market Size, By Value, 2020H-2030F (USD Billion)
  • Figure 24: Americas Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, 2023 (%)
  • Figure 25: Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Candidiasis, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 26: Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Aspergillosis, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 27: Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Antifungal Medications, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 28: Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Combination Therapy, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 29: Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Surgical Intervention, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 30: Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Hospitals, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 31: Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Clinics, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 32: Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Other End-users, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 33: United States Systemic Aspergillosis and Systemic Candidiasis Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 34: United States Systemic Aspergillosis and Systemic Candidiasis Market Value, By Treatment Approach, 2023 (USD Billion)
  • Figure 35: United States Systemic Aspergillosis and Systemic Candidiasis Market Share, By Type, By Value, 2023 (%)
  • Figure 36: United States Systemic Aspergillosis and Systemic Candidiasis Market Share, By Treatment Approach, By Value, 2023 (%)
  • Figure 37: United States Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, By Value, 2023 (%)
  • Figure 38: Canada Systemic Aspergillosis and Systemic Candidiasis Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 39: Canada Systemic Aspergillosis and Systemic Candidiasis Market Value, By Treatment Approach, 2023 (USD Billion)
  • Figure 40: Canada Systemic Aspergillosis and Systemic Candidiasis Market Share, By Type, By Value, 2023 (%)
  • Figure 41: Canada Systemic Aspergillosis and Systemic Candidiasis Market Share, By Treatment Approach, By Value, 2023 (%)
  • Figure 42: Canada Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, By Value, 2023 (%)
  • Figure 43: Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 44: Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market Value, By Treatment Approach, 2023 (USD Billion)
  • Figure 45: Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market Share, By Type, By Value, 2023 (%)
  • Figure 46: Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market Share, By Treatment Approach, By Value, 2023 (%)
  • Figure 47: Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, By Value, 2023 (%)
  • Figure 48: Europe Systemic Aspergillosis and Systemic Candidiasis Market Size, By Value, 2020H-2030F (USD Billion)
  • Figure 49: Europe Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, 2023 (%)
  • Figure 50: Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Candidiasis, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 51: Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Aspergillosis, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 52: Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Antifungal Medications, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 53: Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Combination Therapy, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 54: Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Surgical Intervention, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 55: Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Hospitals, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 56: Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Clinics, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 57: Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Other End-users, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 58: Germany Systemic Aspergillosis and Systemic Candidiasis Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 59: Germany Systemic Aspergillosis and Systemic Candidiasis Market Value, By Treatment Approach, 2023 (USD Billion)
  • Figure 60: Germany Systemic Aspergillosis and Systemic Candidiasis Market Share, By Type, By Value, 2023 (%)
  • Figure 61: Germany Systemic Aspergillosis and Systemic Candidiasis Market Share, By Treatment Approach, By Value, 2023 (%)
  • Figure 62: Germany Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, By Value, 2023 (%)
  • Figure 63: United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 64: United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market Value, By Treatment Approach, 2023 (USD Billion)
  • Figure 65: United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market Share, By Type, By Value, 2023 (%)
  • Figure 66: United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market Share, By Treatment Approach, By Value, 2023 (%)
  • Figure 67: United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, By Value, 2023 (%)
  • Figure 68: France Systemic Aspergillosis and Systemic Candidiasis Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 69: France Systemic Aspergillosis and Systemic Candidiasis Market Value, By Treatment Approach, 2023 (USD Billion)
  • Figure 70: France Systemic Aspergillosis and Systemic Candidiasis Market Share, By Type, By Value, 2023 (%)
  • Figure 71: France Systemic Aspergillosis and Systemic Candidiasis Market Share, By Treatment Approach, By Value, 2023 (%)
  • Figure 72: France Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, By Value, 2023 (%)
  • Figure 73: Italy Systemic Aspergillosis and Systemic Candidiasis Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 74: Italy Systemic Aspergillosis and Systemic Candidiasis Market Value, By Treatment Approach, 2023 (USD Billion)
  • Figure 75: Italy Systemic Aspergillosis and Systemic Candidiasis Market Share, By Type, By Value, 2023 (%)
  • Figure 76: Italy Systemic Aspergillosis and Systemic Candidiasis Market Share, By Treatment Approach, By Value, 2023 (%)
  • Figure 77: Italy Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, By Value, 2023 (%)
  • Figure 78: Spain Systemic Aspergillosis and Systemic Candidiasis Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 79: Spain Systemic Aspergillosis and Systemic Candidiasis Market Value, By Treatment Approach, 2023 (USD Billion)
  • Figure 80: Spain Systemic Aspergillosis and Systemic Candidiasis Market Share, By Type, By Value, 2023 (%)
  • Figure 81: Spain Systemic Aspergillosis and Systemic Candidiasis Market Share, By Treatment Approach, By Value, 2023 (%)
  • Figure 82: Spain Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, By Value, 2023 (%)
  • Figure 83: Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 84: Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market Value, By Treatment Approach, 2023 (USD Billion)
  • Figure 85: Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market Share, By Type, By Value, 2023 (%)
  • Figure 86: Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market Share, By Treatment Approach, By Value, 2023 (%)
  • Figure 87: Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, By Value, 2023 (%)
  • Figure 88: Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Size, By Value, 2020H-2030F (USD Billion)
  • Figure 89: Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, 2023 (%)
  • Figure 90: Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Candidiasis, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 91: Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Aspergillosis, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 92: Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Antifungal Medications, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 93: Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Combination Therapy, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 94: Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Surgical Intervention, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 95: Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Hospitals, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 96: Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Clinics, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 97: Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Other End-users, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 98: China Systemic Aspergillosis and Systemic Candidiasis Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 99: China Systemic Aspergillosis and Systemic Candidiasis Market Value, By Treatment Approach, 2023 (USD Billion)
  • Figure 100: China Systemic Aspergillosis and Systemic Candidiasis Market Share, By Type, By Value, 2023 (%)
  • Figure 101: China Systemic Aspergillosis and Systemic Candidiasis Market Share, By Treatment Approach, By Value, 2023 (%)
  • Figure 102: China Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, By Value, 2023 (%)
  • Figure 103: Japan Systemic Aspergillosis and Systemic Candidiasis Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 104: Japan Systemic Aspergillosis and Systemic Candidiasis Market Value, By Treatment Approach, 2023 (USD Billion)
  • Figure 105: Japan Systemic Aspergillosis and Systemic Candidiasis Market Share, By Type, By Value, 2023 (%)
  • Figure 106: Japan Systemic Aspergillosis and Systemic Candidiasis Market Share, By Treatment Approach, By Value, 2023 (%)
  • Figure 107: Japan Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, By Value, 2023 (%)
  • Figure 108: India Systemic Aspergillosis and Systemic Candidiasis Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 109: India Systemic Aspergillosis and Systemic Candidiasis Market Value, By Treatment Approach, 2023 (USD Billion)
  • Figure 110: India Systemic Aspergillosis and Systemic Candidiasis Market Share, By Type, By Value, 2023 (%)
  • Figure 111: India Systemic Aspergillosis and Systemic Candidiasis Market Share, By Treatment Approach, By Value, 2023 (%)
  • Figure 112: India Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, By Value, 2023 (%)
  • Figure 113: Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 114: Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Value, By Treatment Approach, 2023 (USD Billion)
  • Figure 115: Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Share, By Type, By Value, 2023 (%)
  • Figure 116: Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Share, By Treatment Approach, By Value, 2023 (%)
  • Figure 117: Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, By Value, 2023 (%)
  • Figure 118: Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Size, By Value, 2020H-2030F (USD Billion)
  • Figure 119: Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, 2023 (%)
  • Figure 120: Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market, By Candidiasis, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 121: Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market, By Aspergillosis, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 122: Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market, By Antifungal Medications, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 123: Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market, By Combination Therapy, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 124: Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market, By Surgical Intervention, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 125: Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market, By Hospitals, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 126: Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market, By Clinics, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 127: Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market, By Other End-users, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 128: Market Share of Prominent Companies of Systemic Aspergillosis and Systemic Candidiasis Market, 2023 (%)
  • Figure 129: Sanofi Revenues, 2020-2022 (USD Million)
  • Figure 130: Sanofi Revenues, By Geographic Segments, 2022 (%)
  • Figure 131: Sanofi Revenue , By Business Segments, 2022 (%)
  • Figure 132: Cipla Revenues, 2020-2022 (USD Million)
  • Figure 133: Cipla Revenues, By Geographic Segments, 2022 (%)
  • Figure 134: Pfizer Revenues, 2020-2022 (USD Million)
  • Figure 135: Pfizer Revenues, By Business Segments, 2023 (%)
  • Figure 136: Pfizer Inc. Revenue , By Geographical Segments, 2023 (%)
  • Figure 137: GSK PLC Revenue, 2020-2022 (USD Million)
  • Figure 138: GSK PLC Revenue , By Business Segments, 2022 (%)
  • Figure 139: GSK PLC Revenue, By Geography Segment, 2022 (%)
  • Figure 140: Novartis Revenue, 2020-2022 (USD Million)
  • Figure 141: Novartis Revenue, By Business Segments, 2022 (%)
  • Figure 142: Novartis Revenue, By Geographical Segments, 2022 (%)
  • Figure 143: Bayer AG Revenues, 2020-2022 (USD Million)
  • Figure 144: Bayer AG Revenues, By Geographic Segments, 2022 (%)
  • Figure 145: Bayer AG Revenues, By Business Segments, 2022 (%)
  • Figure 146: Merck & Co., Inc. Revenues, 2020-2022 (USD Million)
  • Figure 147: Merck & Co., Inc. Revenues, By Geographic Segments, 2022 (%)
  • Figure 148: Merck & Co., Inc. Revenue , By Business Segments, 2022 (%)
  • Figure 149: Roche Revenues, 2021-2023 (USD Million)
  • Figure 150: Roche Revenue , By Sales Division, 2023 (%)
  • Figure 151: Roche Revenue , By Geographical Segment, 2023 (%)
  • Figure 152: Abbott Laboratories Revenues, 2021-2023 (USD Million)
  • Figure 153: Abbott Laboratories Revenues, By Geographic Segments, 2023 (%)
  • Figure 154: Abbott Laboratories Revenue , By Business Segments, 2023 (%)
  • Figure 155: Gilead Sciences, Inc. Revenues, 2021-2023 (USD Million)
  • Figure 156: Gilead Sciences, Inc. Revenues, By Geographic Segments, 2023 (%)
  • Figure 157: Gilead Sciences, Inc. Revenue , By Therapeutic Area, 2023 (%)

List of Tables

Table A1: Global Impact of Macro Economic Factors, By Region

Table A2: Annual incidence of commoner life-threatening fungal infections

Table A3: Antifungal Therapies for Systemic Aspergillosis And Systemic Candidiasis in Pipeline

Table A4: United States Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2020-2023 (USD Billion)

Table A5: United States Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2025-2030 (USD Billion)

Table A6: United States Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2020-2023 (USD Billion)

Table A7: United States Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2025-2030 (USD Billion)

Table A8: United States Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2020-2023 (USD Billion)

Table A9: United States Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2025-2030 (USD Billion)

Table A10: Canada Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2020-2023 (USD Billion)

Table A11: Canada Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2025-2030 (USD Billion)

Table A12: Canada Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2020-2023 (USD Billion)

Table A13: Canada Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2025-2030 (USD Billion)

Table A14: Canada Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2020-2023 (USD Billion)

Table A15: Canada Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2025-2030 (USD Billion)

Table A16: Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2020-2023 (USD Billion)

Table A17: Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2025-2030 (USD Billion)

Table A18: Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2020-2023 (USD Billion)

Table A19: Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2025-2030 (USD Billion)

Table A20: Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2020-2023 (USD Billion)

Table A21: Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2025-2030 (USD Billion)

Table A22: Germany Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2020-2023 (USD Billion)

Table A23: Germany Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2025-2030 (USD Billion)

Table A24: Germany Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2020-2023 (USD Billion)

Table A25: Germany Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2025-2030 (USD Billion)

Table A26: Germany Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2020-2023 (USD Billion)

Table A27: Germany Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2025-2030 (USD Billion)

Table A28: United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2020-2023 (USD Billion)

Table A29: United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2025-2030 (USD Billion)

Table A30: United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2020-2023 (USD Billion)

Table A31: United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2025-2030 (USD Billion)

Table A32: United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2020-2023 (USD Billion)

Table A33: United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2025-2030 (USD Billion)

Table A34: France Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2020-2023 (USD Billion)

Table A35: France Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2025-2030 (USD Billion)

Table A36: France Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2020-2023 (USD Billion)

Table A37: France Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2025-2030 (USD Billion)

Table A38: France Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2020-2023 (USD Billion)

Table A39: France Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2025-2030 (USD Billion)

Table A40: Italy Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2020-2023 (USD Billion)

Table A41: Italy Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2025-2030 (USD Billion)

Table A42: Italy Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2020-2023 (USD Billion)

Table A43: Italy Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2025-2030 (USD Billion)

Table A44: Italy Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2020-2023 (USD Billion)

Table A45: Italy Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2025-2030 (USD Billion)

Table A46: Spain Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2020-2023 (USD Billion)

Table A47: Spain Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2025-2030 (USD Billion)

Table A48: Spain Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2020-2023 (USD Billion)

Table A49: Spain Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2025-2030 (USD Billion)

Table A50: Spain Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2020-2023 (USD Billion)

Table A51: Spain Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2025-2030 (USD Billion)

Table A52: Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2020-2023 (USD Billion)

Table A53: Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2025-2030 (USD Billion)

Table A54: Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2020-2023 (USD Billion)

Table A55: Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2025-2030 (USD Billion)

Table A56: Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2020-2023 (USD Billion)

Table A57: Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2025-2030 (USD Billion)

Table A58: China Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2020-2023 (USD Billion)

Table A59: China Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2025-2030 (USD Billion)

Table A60: China Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2020-2023 (USD Billion)

Table A61: China Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2025-2030 (USD Billion)

Table A62: China Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2020-2023 (USD Billion)

Table A63: China Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2025-2030 (USD Billion)

Table A64: Japan Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2020-2023 (USD Billion)

Table A65: Japan Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2025-2030 (USD Billion)

Table A66: Japan Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2020-2023 (USD Billion)

Table A67: Japan Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2025-2030 (USD Billion)

Table A68: Japan Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2020-2023 (USD Billion)

Table A69: Japan Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2025-2030 (USD Billion)

Table A70: India Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2020-2023 (USD Billion)

Table A71: India Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2025-2030 (USD Billion)

Table A72: India Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2020-2023 (USD Billion)

Table A73: India Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2025-2030 (USD Billion)

Table A74: India Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2020-2023 (USD Billion)

Table A75: India Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2025-2030 (USD Billion)

Table A76: Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2020-2023 (USD Billion)

Table A77: Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2025-2030 (USD Billion)

Table A78: Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2020-2023 (USD Billion)

Table A79: Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2025-2030 (USD Billion)

Table A80: Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2020-2023 (USD Billion)

Table A81: Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2025-2030 (USD Billion)

Table A82: Sanofi Key Financials, 2020-2022

Table A83: Cipla Key Financials, 2020-2022

Table A84: Pfizer Key Financials, 2021-2023

Table A85: GSK PLC Key Company Financials, 2020-2022

Table A86: Novartis Key Company Financials, 2020-2022

Table A87: Bayer AG Key Financials, 2020-2022

Table A88: Merck & Co., Inc. Key Financials, 2020-2022

Table A89: Roche Key Financials, 2021-2023

Table A90: Abbott Laboratories Key Financials, 2021-2023

Table A91: Gilead Sciences, Inc. Key Financials, 2021-2023